tirzepatide peptide compound | C225H348N48O68 | CID 156588324 CID 163285897 | C225H348N48O68 |

Cell Metab 2013

TIER 1 (72mg total) $350 total for 8-10 week supply Monthly cost breakdown: $140 Recommended if new to treatment or for those on 2-4.5mg/week TIER 2 (72mg total) $350 total for 8-10 week supply Monthly cost breakdown: $140-$175 based on weekly dose Recommended for those on 5-7mg/week TIER 3 (72mg total) $350 total for 8-10 week supply Monthly cost breakdown: $140-$175 based on weekly dose Recommended for those on 8-9mg/week TIER 4 (144mg total) $380 total for 10 week supply Monthly cost breakdown: $152 based on weekly dose Recommended for those on 10mg/week and up EXTENDED PLANS All extended plans are supplied with a minimum of 3 vials to support extended use Foundation Plan (108mg total) $460 total for 3-4+ supply Monthly cost breakdown: $115 Recommended if new to treatment or for those on doses up to 7mg/week Momentum Plan (144mg total) $485 total for 3-4+ supply Monthly cost breakdown: $121 Recommended for doses up to 9mg/week Elevate Plan (216mg total) $515 for 3-4+ month supply Monthly cost breakdown: $128 Recommended for doses of 10mg/week & up ReviveRx Pharmacy - Tirzepatide/B6 Injection Up to 90 days BUD

Meet the Team Dr

muciniphila works indirectly, through gut barrier function and inflammation modulation, which is a slower, subtler pathway." Meet our experts Hector Perez , MD, board-certified bariatric surgeon Kezia Joy , RDN, medical adviser at Welzo Our health content is for informational purposes only and is not intended as professional medical advice

Aug 14: In what is expected to become a multibillion-dollar blockbuster, Pfizers BCMAxCD3 bispecific antibody Elrexfio (elranatamab-bcmm) has secured an FDA accelerated approval as another off-the-shelf treatment option for patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior lines of therapy